Published in Biochem Pharmacol on February 17, 2011
NMDA receptor and schizophrenia: a brief history. Schizophr Bull (2012) 1.59
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov (2013) 1.27
Targeting glutamate synapses in schizophrenia. Trends Mol Med (2011) 1.06
The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome. Am J Med Genet A (2015) 0.83
The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci (2016) 0.82
Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Rev Neurother (2012) 0.81
Glycine transporter 1 is a target for the treatment of epilepsy. Neuropharmacology (2015) 0.80
d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption. Eur J Neurosci (2015) 0.79
Glycine transporter type 2 (GlyT2) inhibitor ameliorates bladder overactivity and nociceptive behavior in rats. Eur Urol (2012) 0.78
PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination. PLoS One (2015) 0.77
Intact working memory in the absence of forebrain neuronal glycine transporter 1. Behav Brain Res (2012) 0.76
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission. Psychopharmacology (Berl) (2011) 0.76
Copper-Catalyzed Alkylation of Nitroalkanes with α-Bromonitriles: Synthesis of β-Cyanonitroalkanes. Org Lett (2016) 0.75
Deletion of forebrain glycine transporter 1 enhances conditioned freezing to a reliable, but not an ambiguous, cue for threat in a conditioned freezing paradigm. Behav Brain Res (2014) 0.75
Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1. EJNMMI Res (2012) 0.75
A confusing coincidence: neonatal hypoglycemic seizures and hyperekplexia. Case Rep Med (2014) 0.75
Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science (2013) 3.83
The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci (2006) 3.03
Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol (2004) 2.38
Abnormal differentiation of newborn granule cells in age-related working memory impairments. Neurobiol Aging (2008) 2.38
Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci (2004) 2.25
Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun (2007) 1.86
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest (2008) 1.86
Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol (2005) 1.80
A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors. J Clin Invest (2011) 1.79
Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms. Neurosci Biobehav Rev (2003) 1.78
In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev (2009) 1.74
Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol (2009) 1.73
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev (2005) 1.70
Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research. Neurosci Biobehav Rev (2005) 1.70
Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat. Behav Brain Res (2004) 1.65
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res (2011) 1.62
Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials (2008) 1.57
Enhanced recognition memory following glycine transporter 1 deletion in forebrain neurons. Behav Neurosci (2007) 1.56
A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation. Am J Respir Crit Care Med (2014) 1.55
Double dissociation of the effects of selective nucleus accumbens core and shell lesions on impulsive-choice behaviour and salience learning in rats. Eur J Neurosci (2005) 1.54
Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain (2005) 1.51
Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain (2007) 1.50
A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull (2008) 1.49
Hippocampal modulation of sensorimotor processes. Prog Neurobiol (2003) 1.47
Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol (2004) 1.45
The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist (2007) 1.42
Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci (2004) 1.42
Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol (2006) 1.40
Inhibition of Adenosine Kinase Attenuates Acute Lung Injury. Crit Care Med (2016) 1.39
Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J Neurochem (2004) 1.38
Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia (2003) 1.38
Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol (2005) 1.37
Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus (2003) 1.35
Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci (2011) 1.35
Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J Cereb Blood Flow Metab (2006) 1.30
Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol (2007) 1.27
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov (2013) 1.27
Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun (2005) 1.27
A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs. J Neurosci (2008) 1.27
A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci (2010) 1.24
Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci (2006) 1.23
Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol (2007) 1.23
Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol (2008) 1.21
GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur J Neurosci (2004) 1.21
Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology (2008) 1.18
Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J Cereb Blood Flow Metab (2007) 1.18
Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol (2009) 1.18
Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology (2007) 1.18
Specific neuronal protein: a new tool for histological evaluation of excitotoxic lesions. Physiol Behav (2002) 1.17
Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity. J Neurosci (2002) 1.14
Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology (2007) 1.13
Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology (2010) 1.12
Performance of the marmoset monkey on computerized tasks of attention and working memory. Brain Res Cogn Brain Res (2004) 1.12
Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory. Behav Brain Res (2002) 1.11
Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol (2005) 1.11
Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One (2009) 1.10
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest (2013) 1.09
Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci Lett (2005) 1.09
The impact of voluntary exercise on mental health in rodents: a neuroplasticity perspective. Behav Brain Res (2008) 1.09
Silk fibroin encapsulated powder reservoirs for sustained release of adenosine. J Control Release (2010) 1.09
The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development. Dev Psychobiol (2006) 1.08
DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther (2007) 1.08
A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance. Epilepsia (2009) 1.07
Early deprivation and behavioral and physiological responses to social separation/novelty in the marmoset. Pharmacol Biochem Behav (2002) 1.07
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull (2008) 1.07
Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry (2002) 1.06
ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis (2003) 1.06
Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res (2008) 1.05
Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behav Brain Res (2006) 1.05
Disruption of hippocampus-regulated behavioural and cognitive processes by heterozygous constitutive deletion of SynGAP. Eur J Neurosci (2010) 1.05
Neuroprotection in ischemic mouse brain induced by stem cell-derived brain implants. J Cereb Blood Flow Metab (2006) 1.04
Early life stress: long-term physiological impact in rodents and primates. News Physiol Sci (2002) 1.03
Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res (2006) 1.03
Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett (2004) 1.02
Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol Aging (2007) 1.02
Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02